GenFleet Therapeutics (Shanghai) Inc
HKEX:2595
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
GenFleet Therapeutics (Shanghai) Inc
HKEX:2595
|
CN |
|
I
|
InterContinental Hotels Group PLC
NYSE:IHG
|
UK |
|
JSTI Group
SZSE:300284
|
CN |
|
Shandong Xinneng Taishan Power Generation Co Ltd
SZSE:000720
|
CN |
|
B
|
Bear Electric Appliance Co Ltd
SZSE:002959
|
CN |
|
GYM Group PLC
LSE:GYM
|
UK |
|
Moelis & Co
NYSE:MC
|
US |
|
T
|
TianJin 712 Communication & Broadcasting Co Ltd
SSE:603712
|
CN |
|
Smurfit WestRock PLC
LSE:SWR
|
IE |
|
Eden Innovations Ltd
ASX:EDEDA
|
AU |
|
Beijing GeoEnviron Engineering & Technology Inc
SSE:603588
|
CN |
|
KDDL Ltd
NSE:KDDL
|
IN |
|
BASF India Ltd
NSE:BASF
|
IN |
|
Microstrategy Inc
NASDAQ:MSTR
|
US |
|
N
|
Netlink Solutions (India) Ltd
BSE:509040
|
IN |
|
One Point One Solutions Ltd
NSE:ONEPOINT
|
IN |
|
B
|
BF Investment Ltd
NSE:BFINVEST
|
IN |
|
Findi Ltd
ASX:FND
|
AU |
|
India Cements Ltd
NSE:INDIACEM
|
IN |
Multiples-Based Value
The Multiples-Based Value of one
GenFleet Therapeutics (Shanghai) Inc
stock under the Base Case scenario is
hidden
HKD.
Compared to the current market price of 36.5 HKD,
GenFleet Therapeutics (Shanghai) Inc
is
hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Multiples Across Competitors
Competitors Multiples
GenFleet Therapeutics (Shanghai) Inc Competitors
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CN |
|
GenFleet Therapeutics (Shanghai) Inc
HKEX:2595
|
12.6B HKD | 105.9 | -16.4 | -37.3 | -35.6 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 690 872.8 | -160 127.7 | -194 446.1 | -192 227.3 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
369.2B USD | 6 | 88.2 | 14.6 | 20.3 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
187.5B USD | 5.1 | 24.3 | 14.1 | 14.1 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
173.4B USD | 5.9 | 20.4 | 12.7 | 15.7 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
111.4B USD | 9.3 | 28.2 | 21.2 | 22.1 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 091 | -533.6 | -581 | -565.5 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
80.5B USD | 5.6 | 17.9 | 13.3 | 15.2 | |
| AU |
|
CSL Ltd
ASX:CSL
|
67B AUD | 3.1 | 34 | 11.3 | 14.2 | |
| NL |
|
argenx SE
XBRU:ARGX
|
39.6B EUR | 11.3 | 36.2 | 39.3 | 40.1 | |
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 20.1 | -61.8 | -66.6 | -60.1 |